Back to Agenda
Session 8A: Podium Pearls
Session Chair(s)
Julia Petses, PharmD
Global Head, Medical Information Excellence and SEC Established and Rare Franchi
Novartis, United States
Medical communications professionals will be presenting their successes, challenges, and “pearls of wisdom” on various topics through podium presentations.
Learning Objective : At the conclusion of this session, participants should be able to:
•Discuss and share best practices, experiences, and innovative processes for medical communications topics related to social media, new technologies, information exchange platforms, and expanding medical information roles
Speaker(s)
US MEDICAL INFORMATION WEBSITES BENCHMARKING: HOW IS THE INDUSTRY FAIRING IN USABILITY?
Rania Gaspo, PhD
Pfizer Inc, Canada
Director, Global Therapy Area Team Lead, External Medical Communications
SYSTEMATIC PROACTIVE REVIEW OF ONLINE DRUG COMPENDIA MONOGRAPHS
Taleen Kalebjian, PharmD
Gilead Sciences, Inc., United States
Senior Manager, Medical Information
COMPARISON OF MEDICAL INFORMATION SERVICES PRE- AND POST- SPLIT OF A PHARMA COMPANY: COMBINING TWO CUSTOMER FEEDBACK METHODS
Sarika Sood, MD
Abbvie, United States
Sr. Director Global Medical Information
EFFECTIVE GLOBALIZATION IN A MATRIX ORGANIZATIONAL STRUCTURE
Thomas Malieckal, PharmD
Celgene, United States
Sr Director, Global Medical Information
ADDING CLARITY BEYOND VERBAL RESPONSE ONLY: PROVIDING WRITTEN MEDICAL INFORMATION RESPONSES TO PATIENTS
Brandi Fannon Gregg, PharmD
UCB, Inc. , United States
HCP Associate, UCBCares
MEDICAL INFORMATION (MI) SOCIAL MEDIA ACTIVITIES: IMPACT OF POST TYPE AND REFERRALS TO MI
Alicia Alexander Cadogan, PharmD, RPh
Pfizer Inc, United States
Director, Oncology Medical Information
Have an account?